Update on Proposed Transaction
Source: RNS
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (596/2014/EU) AS THE SAME HAS BEEN RETAINED IN UK LAW AS AMENDED BY THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
27 September 2024
R8 Capital Investments plc
(the "Company" or "R8")
Update on Proposed Transaction
The Company announces that the proposed acquisition of Redwood Financial Partners Limited and its wholly-owned subsidiary, Redwood Bank Limited, is continuing to progress and is now expected to complete in Q1 2025. Whilst progress has been subject to unexpected delays over the summer period, the Company is optimistic that the acquisition will be completed in accordance with the above-mentioned revised timeline.
Whilst there can be no certainty that the acquisition will complete and it remains subject to, amongst other things, formal terms being agreed and the completion of legal and financial due diligence and regulatory approvals, the directors of R8 remain confident of a successful outcome.
A further announcement will be made in due course.
-Ends-
Further information:
R8 Capital Investments plc
Jonathan Rowland / Richard Morecroft info@r8plc.com
Peterhouse Capital Limited + 44 (0) 20 7469 0930
Corporate Broker
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.